368 related articles for article (PubMed ID: 8985399)
1. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection.
Srikiatkhachorn A; Braciale TJ
J Virol; 1997 Jan; 71(1):678-85. PubMed ID: 8985399
[TBL] [Abstract][Full Text] [Related]
2. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.
Srikiatkhachorn A; Braciale TJ
J Exp Med; 1997 Aug; 186(3):421-32. PubMed ID: 9236194
[TBL] [Abstract][Full Text] [Related]
3. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease.
Spender LC; Hussell T; Openshaw PJ
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1751-8. PubMed ID: 9680139
[TBL] [Abstract][Full Text] [Related]
4. Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or gamma interferon.
Bembridge GP; Lopez JA; Cook R; Melero JA; Taylor G
J Virol; 1998 May; 72(5):4080-7. PubMed ID: 9557697
[TBL] [Abstract][Full Text] [Related]
5. Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein.
Bembridge GP; Garcia-Beato R; López JA; Melero JA; Taylor G
J Immunol; 1998 Sep; 161(5):2473-80. PubMed ID: 9725246
[TBL] [Abstract][Full Text] [Related]
6. Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge.
Bembridge GP; Lopez JA; Bustos R; Melero JA; Cook R; Mason H; Taylor G
J Virol; 1999 Dec; 73(12):10086-94. PubMed ID: 10559323
[TBL] [Abstract][Full Text] [Related]
7. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
[TBL] [Abstract][Full Text] [Related]
8. Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism.
Johnson TR; Graham BS
J Virol; 1999 Oct; 73(10):8485-95. PubMed ID: 10482601
[TBL] [Abstract][Full Text] [Related]
9. Different patterns of cytokine induction in cultures of respiratory syncytial (RS) virus-specific human TH cell lines following stimulation with RS virus and RS virus proteins.
Jackson M; Scott R
J Med Virol; 1996 Jul; 49(3):161-9. PubMed ID: 8818960
[TBL] [Abstract][Full Text] [Related]
10. The attachment (G) glycoprotein of respiratory syncytial virus contains a single immunodominant epitope that elicits both Th1 and Th2 CD4+ T cell responses.
Varga SM; Wissinger EL; Braciale TJ
J Immunol; 2000 Dec; 165(11):6487-95. PubMed ID: 11086089
[TBL] [Abstract][Full Text] [Related]
11. Characterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model.
Liu J; Ruckwardt TJ; Chen M; Johnson TR; Graham BS
J Virol; 2009 May; 83(10):4934-41. PubMed ID: 19264776
[TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.
Becker Y
Virus Genes; 2006 Oct; 33(2):235-52. PubMed ID: 16972040
[TBL] [Abstract][Full Text] [Related]
13. IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.
Johnson TR; Parker RA; Johnson JE; Graham BS
J Immunol; 2003 Feb; 170(4):2037-45. PubMed ID: 12574374
[TBL] [Abstract][Full Text] [Related]
14. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection.
Hussell T; Georgiou A; Sparer TE; Matthews S; Pala P; Openshaw PJ
J Immunol; 1998 Dec; 161(11):6215-22. PubMed ID: 9834108
[TBL] [Abstract][Full Text] [Related]
15. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.
Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL
J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914
[TBL] [Abstract][Full Text] [Related]
16. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus.
Hancock GE; Speelman DJ; Heers K; Bortell E; Smith J; Cosco C
J Virol; 1996 Nov; 70(11):7783-91. PubMed ID: 8892899
[TBL] [Abstract][Full Text] [Related]
17. The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia.
Olson MR; Hartwig SM; Varga SM
J Immunol; 2008 Dec; 181(11):7958-68. PubMed ID: 19017987
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo.
Aung S; Tang YW; Graham BS
J Virol; 1999 Nov; 73(11):8944-9. PubMed ID: 10515999
[TBL] [Abstract][Full Text] [Related]
19. Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus.
Castilow EM; Olson MR; Meyerholz DK; Varga SM
J Virol; 2008 Mar; 82(5):2196-207. PubMed ID: 18094193
[TBL] [Abstract][Full Text] [Related]
20. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge.
Johnson TR; Johnson JE; Roberts SR; Wertz GW; Parker RA; Graham BS
J Virol; 1998 Apr; 72(4):2871-80. PubMed ID: 9525607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]